EDGAR Filing Documents for 0001564590-21-028461

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001564590-21-028461

Filing Date

2021-05-17

Accepted

2021-05-17 17:11:25

Documents

Period of Report

2021-05-17

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	lmnl-6k_20210517.htm	6-K	24012
2	EX-99.1	lmnl-ex991_33.htm	EX-99.1	52684
3	EX-99.2	lmnl-ex992_57.htm	EX-99.2	894727
4	EX-99.3	lmnl-ex993_56.htm	EX-99.3	2070186
5	EX-99.4	lmnl-ex994_7.htm	EX-99.4	19784
6	EX-99.5	lmnl-ex995_9.htm	EX-99.5	20292
7	GRAPHIC	gcof0o43lpm4000001.jpg	GRAPHIC	12047
8	GRAPHIC	gckq3nu2qn2s000001.jpg	GRAPHIC	38195
9	GRAPHIC	gbi4ljw0qv2r000001.jpg	GRAPHIC	12047
	Complete submission text file	0001564590-21-028461.txt		3169005

Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4

Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 450-781-0115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)